PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Queen Mary School, Nanchang University, Nanchang, Jiangxi, China.\', \'Jiangxi Province Key Laboratory of Tumor Pathogenesis and Molecular Pathology and Department of Pathophysiology, School of Basic Medical Sciences, Nanchang University, Nanchang, Jiangxi, China.\', \'Queen Mary School, Nanchang University, Nanchang, Jiangxi, China. zluo559914@ncu.edu.cn.\', \'Jiangxi Province Key Laboratory of Tumor Pathogenesis and Molecular Pathology and Department of Pathophysiology, School of Basic Medical Sciences, Nanchang University, Nanchang, Jiangxi, China. zluo559914@ncu.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s12879-021-05915-0
?:doi
?:hasPublicationType
?:journal
  • BMC infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 33618678
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.576
?:rankingScore_hIndex
  • 80
is ?:relation_isRelatedTo_publication of
?:title
  • Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all